Living liver donor death related to complications of Myeloma

Liver Transplantation

Volumn 15, Issue 3, 2009, Pages 326-329

  Melloul, Emmanuel ^a   Dondero, Federica ^a   Paugam Burtz, Catherine ^a   Bouadma, Lila ^b   Arnulf, Bertrand ^c   Belghiti, Jacques ^a  

^a BEAUJON HOSPITAL   (France)

^b BICHAT HOSPITAL   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; HEPARIN; IMMUNOGLOBULIN G;

ACINETOBACTER INFECTION; ADULT; ARTICLE; ARTIFICIAL VENTILATION; ATELECTASIS; BLOOD CLOTTING DISORDER; CASE REPORT; CONTINUOUS HEMOFILTRATION; DEATH; ESCHERICHIA COLI INFECTION; HEMOPTYSIS; HOSPITAL INFECTION; HUMAN; HUMAN TISSUE; IMMUNOELECTROPHORESIS; INFERIOR CAVA VEIN; KIDNEY FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; LUNG EMBOLISM; LUNG HEMORRHAGE; LUNG INFECTION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTIPLE ORGAN FAILURE; MYELOGRAPHY; MYELOMA; NECROSIS; OLIGURIA; PLASMA CELL; PLEURA EFFUSION; PLEURA EMPYEMA; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SALIVARY GLAND BIOPSY; SEPTIC SHOCK; VEIN THROMBOSIS; VENTILATOR ASSOCIATED PNEUMONIA;

FATAL OUTCOME; HUMANS; LIVER; LIVER CIRRHOSIS, ALCOHOLIC; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; TREATMENT OUTCOME;

EID: 67649212669     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21685     Document Type: Article

References (25)

1. Broering DC, Wilms C, Bok P, Fischer L, Mueller L, Hillert C, et al. Evolution of donor morbidity in living related liver transplantation - a single center analysis of 165 cases. Ann Surg 2004;240:1013-1026.
2. Adam R. ELTR report about living liver donation in Europe. ELTR Report 2003.
3. Trotter JF, Adam R, Lo CM, Kenison J. Documented deaths of hepatic lobe donors for living donor liver transplantation. Liver Transpl 2006;12:1485-1488.
4. Ghobrial RM, Freise CE, Trotter JF, Tong L, Ojo AO, Fair JH, et al. Donor morbidity after living donation for liver transplantation. Gastroenterology 2008;135:468-476.
5. Barr ML, Belghiti J, Villamil FG, Pomfret EA, Sutherland DS, Gruessner RW, et al. A report of the Vancouver Forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines. Transplantation 2006;81:1373-1385.
6. Yi NJ, Suh KS, Cho JY, Lee HW, Cho EH, Yang SH, et al. Three-quarters of right liver donors experienced postoperative complications. Liver Transpl 2007;13:797-806.
7. Miller C, Florman S, Kim-Schluger L, Lento P, De La Garza J, Wu J, et al. Fulminant and fatal gas gangrene of the stomach in a healthy live liver donor. Liver Transpl 2004; 10:1315-1319.
8. Lo CM. Complications and long-term outcome of living liver donors: a survey of 1,508 cases in five Asian centers. Transplantation 2003;75(suppl):S12-S15.
9. Beavers KL, Sandler RS, Fair JH, Johnson MW, Shrestha R. The living donor experience: donor health assessment and outcomes after living donor liver transplantation. Liver Transpl 2001;7:943-947.
10. Umeshita K, Fujiwara K, Kiyosawa K, Makuuchi M, Satomi S, Sugimachi K, et al. Operative morbidity of living liver donors in Japan. Lancet 2003;362:687-690.
11. Middleton PF, Duffield M, Lynch SV, Padbury RT, House T, Stanton P, et al. Living donor liver transplantation-adult donor outcomes: a systematic review. Liver Transpl 2006;12:24-30.
12. Dondero F, Farges O, Belghiti J, Francoz C, Sommacale D, Durand F, et al. A prospective analysis of living-liver donation shows a high rate of adverse events. J Hepatobiliary Pancreat Surg 2006;13:117-122.
13. Augustson BM, Begum G, Dunn JA, Barth NJ, Davies F, Morgan G, et al. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002. Medical Research Council Adult Leukaemia Working Party. J Clin Oncol 2005;23:219-9226.
14. Barlogie B, Tricot G, Anaissie E, Shaughnessy J, Rasmussen E, van Rhee F, et al. Thalidomide and haematopoieticcell transplantation for multiple myeloma. N Engl J Med 2006;354:1021-1030.
15. Auwerda JJ, Sonneveld P, de Maat MP, Leebeek FW. Prothrombotic coagulation abnormalities in patients with newly diagnosed multiple myeloma. Haematologica 2007; 92:279-280.
16. Dondero F, Taillé C, Mal H, Sommacale D, Sauvanet A, Farges O, et al. Respiratory complications: a major concern after right hepatectomy in living liver donors. Transplantation 2006;81:181-186.
17. Bezeaud A, Denninger MH, Dondero F, Saada V, Venisse L, Huisse MG, et al. Hypercoagulability after partial liver resection. Thromb Haemost 2007;98:1252-1256.
18. Irish AB, Winearls CG, Littlewood T. Presentation and survival of patients with severe renal failure and myeloma. QJM 1997;90:773-780.
19. Rayner HC, Haynes AP, Thompson JR, Russell N, Fletcher J. Perspectives in multiple myeloma: survival, prognostic factors and disease complications in a single centre between 1975 and 1988. Q J Med 1991;79:517-525.
20. Murakami H, Hayashi K, Hatsumi N, Saitoh T, Yokohama A, Matsushima T, et al. Risk factors for early death in patients undergoing treatment for multiple myeloma. Ann Hematol 2001;80:452-455.
21. Perri RT, Hebbel RP, Oken MM. Influence of treatment and response status on infection risk in multiple myeloma. Am J Med 1981;71:935-940.
22. Eleutherakis-Papaiakovou V, Bamias A, Gika D, Simeonidis A, Pouli A, Anagnostopoulos A, et al. Renal failure in multiple myeloma: incidence, correlations, and prognostic significance. Leuk Lymphoma 2007;48:337-341.
23. Analysis and management of renal failure in fourth MRC myelomatosis trial: MRC working group party on leukaemia in adults. Br Med J (Clin Res Ed) 1984;288:1411-1416.
24. Pratt G, Goodyear O, Moss P. Immunodeficiency and immunotherapy in multiple myeloma. Br J Haematol 2007; 138:563-579.
25. Longo DL. Plasma cell disorders. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's Principles of Internal Medicine. 13th ed. New York: McGraw-Hill; 1994:1618-1625.